Advisor Group, Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,000
-44.4%
1,000
-66.7%
0.00%
Q3 2019$9,000
+125.0%
3,000
+200.0%
0.00%
Q2 2019$4,0000.0%1,0000.0%0.00%
Q1 2019$4,000
+33.3%
1,0000.0%0.00%
Q4 2018$3,000
-40.0%
1,0000.0%0.00%
Q3 2018$5,000
-28.6%
1,0000.0%0.00%
Q2 2018$7,0001,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders